Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.
about
Diverse molecular targets for therapeutic strategies in Alzheimer's disease5-HT6 receptors and Alzheimer's diseaseAVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in ratsThe Serotonin Receptor 6 Antagonist Idalopirdine and Acetylcholinesterase Inhibitor Donepezil Have Synergistic Effects on Brain Activity-A Functional MRI Study in the Awake RatIdalopirdine as a treatment for Alzheimer's disease.Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity.The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies.Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis.The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease.Potential serotonergic agents for the treatment of schizophrenia.Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment.AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.Emerging amyloid and tau targeting treatments for Alzheimer's disease.Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats.5-HT6 Receptor Agonist and Antagonist Against β-Amyloid-Peptide-Induced Neurotoxicity in PC-12 Cells.Idalopirdine, a selective 5-HT6 receptor antagonist, reduces food intake and body weight in a model of excessive eating.Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6 receptor antagonists.Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.Restoration of physiological expression of 5-HT6 into the primary cilia of null mutant neurons lengthens both primary cilia and dendrites.
P2860
Q26827193-F5797A05-4B96-4128-998B-FA680C1BD66AQ27006820-70BD7625-5DDC-4152-B2AC-379D6827F99EQ30377178-729B2E03-0DC7-4307-8AA4-118A9050161AQ30444469-B208D683-A01F-40AD-AB33-45F8983560E2Q33785842-E6B4AF9E-4469-4201-85A8-A2CEC99D0B28Q35645744-F2E35948-9AC3-4EC0-ABE9-ABEE31E8789CQ36273778-C00F83E3-F75E-4DE3-8D91-5644A9B5307CQ37826638-B0F906C7-0183-46D9-AEAB-A83A6583D98AQ37954123-A66339B0-DEB1-4026-872C-EF509C73AE8AQ38057380-811400C1-6D61-4ACC-967D-DD740E70B79FQ38225930-0E7A6CBB-6ACE-4B67-8890-58723505C4F3Q38258215-86D896D6-E5B1-4937-B1C6-A34C7776A0F6Q38526546-A787E3A9-D327-4298-8603-1B089E684689Q38627971-A4406D53-CF53-4FED-AA06-963CB1BC38A1Q38635792-45615561-7FDD-45C4-8454-977104993005Q38683808-E211F8E9-0BD5-4160-B075-76EE8DEF6408Q38760655-E1724DFC-E365-4094-905F-744D5CE0D3F5Q39134334-A8BA32F6-5CFB-40B0-8DD4-63FEB6A5A51FQ39296311-B8759BE5-3A59-4765-BA43-EE933A70E423Q39296351-4930C178-B19C-4B81-B3A0-0B5F7C298301Q44655683-F8134D2F-5F82-4E38-8FA0-54792DBE2534Q46407556-83BBF6D2-9D97-4D69-830A-F5110225665EQ47172455-8EEACC9F-79AD-41D8-97C0-FE408A5EC349Q47786351-6EA37CFD-D212-4E52-9ED9-0FB900509F6CQ50576901-2452513E-5C5A-4B07-8EB7-BB81CAC897C3Q52313842-DCA61EC4-4DD1-48BF-B45B-B3243A1E22A6
P2860
Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Lu AE58054, a 5-HT6 antagonist ...... ject recognition test in rats.
@en
Lu AE58054, a 5-HT6 antagonist ...... ject recognition test in rats.
@nl
type
label
Lu AE58054, a 5-HT6 antagonist ...... ject recognition test in rats.
@en
Lu AE58054, a 5-HT6 antagonist ...... ject recognition test in rats.
@nl
prefLabel
Lu AE58054, a 5-HT6 antagonist ...... ject recognition test in rats.
@en
Lu AE58054, a 5-HT6 antagonist ...... ject recognition test in rats.
@nl
P2093
P1476
Lu AE58054, a 5-HT6 antagonist ...... bject recognition test in rats
@en
P2093
Ben Grayson
Bruno Giethlen
David L McKinzie
David L Nelson
Franklin P Bymaster
John M Schaus
Louise M Witten
Mads Kreilgaard
Mette N Poulsen
P304
P356
10.1017/S1461145710000659
P577
2010-06-23T00:00:00Z